Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sorafenib in Relapsed Esophageal/Gastric Adenocarcinoma
NCT01158287Phase 2Completed
- Sponsor
- Cancer Trials Ireland
- Start
- Feb 2009
- Primary completion
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sorafenib in esophageal adenocarcinoma (EAC), gastric adenocarcinoma, sponsored by Cancer Trials Ireland. Started Feb 2009; status: completed.
02
Drugs
sorafenib
03
Conditions
esophageal adenocarcinoma (EAC)gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01158287.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01158287.